ciclosporine/trehalose (HUC2-007) / Huons - LARVOL DELTA

HU007 in Patients With Dry Eye Syndrome (clinicaltrials.gov) - P3 | N=328 | Completed | Sponsor: Huons Co., Ltd. | Recruiting ➔ Completed

Head-to-Head • Trial completion • Dry Eye Disease • Ophthalmology

Treatment Strategies And Targets For Severe Psoriasis (IPC-GLS 2023) - "In clinical practice treatment strategies are not only based on pathophysiological considerations but also on patients' needs and drug availability. Shared-decision making became in important strategy to increase treatment adherence adding to wellbeing as the overarching principle of people-centered health care."

Psoriasis

HU007 in Patients With Dry Eye Syndrome (clinicaltrials.gov) - P3 | N=328 | Recruiting | Sponsor: Huons Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Head-to-Head • Dry Eye Disease • Ophthalmology

HU007 in Patients With Dry Eye Syndrome (clinicaltrials.gov) - P3 | N=328 | Not yet recruiting | Sponsor: Huons Co., Ltd.

Head-to-Head • New P3 trial • Dry Eye Disease • Ophthalmology